StockData
Myomo, Inc. logo

Myomo, Inc. (MYO) stock

MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3035% below fair value
$0.81−0.03 (-3.45%)

Close on Nov 20, 2026Market cap $32.12MP/E –Yield –

Myomo operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Myomo's operating income for the twelve months ending Jun 30, 2026 was -$11.70M. For fiscal 2025 it was -$14.40M. The highest annual figure on record is -$3.28M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.40M–
FY2024Dec 31, 2024-$6.21M–
FY2023Dec 31, 2023-$8.23M–
FY2022Dec 31, 2022-$10.67M–
FY2021Dec 31, 2021-$10.27M–
FY2020Dec 31, 2020-$10.50M–
FY2019Dec 31, 2019-$10.80M–
FY2018Dec 31, 2018-$10.53M–
FY2017Dec 31, 2017-$6.55M–
FY2016Dec 31, 2016-$3.28M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.25M–
Q1 FY2026Mar 31, 2026-$3.16M–
Q4 FY2025Dec 31, 2025-$2.77M–
Q3 FY2025Sep 30, 2025-$3.52M–
Q2 FY2025Jun 30, 2025-$4.59M–
Q1 FY2025Mar 31, 2025-$3.52M–
Q4 FY2024Dec 31, 2024-$245.31K–
Q3 FY2024Sep 30, 2024-$957.55K–
Q2 FY2024Jun 30, 2024-$1.12M–
Q1 FY2024Mar 31, 2024-$3.89M–
Q4 FY2023Dec 31, 2023-$2.43M–
Q3 FY2023Sep 30, 2023-$2.02M–
Q2 FY2023Jun 30, 2023-$1.10M–
Q1 FY2023Mar 31, 2023-$2.67M–
Q4 FY2022Dec 31, 2022-$2.23M–
Q3 FY2022Sep 30, 2022-$2.82M–
Q2 FY2022Jun 30, 2022-$2.90M–
Q1 FY2022Mar 31, 2022-$2.74M–
Q4 FY2021Dec 31, 2021-$2.71M–
Q3 FY2021Sep 30, 2021-$2.03M–
Q2 FY2021Jun 30, 2021-$2.60M–
Q1 FY2021Mar 31, 2021-$2.93M–
Q4 FY2020Dec 31, 2020-$1.69M–
Q3 FY2020Sep 30, 2020-$2.55M–
Q2 FY2020Jun 30, 2020-$2.85M–
Q1 FY2020Mar 31, 2020-$3.42M–
Q4 FY2019Dec 31, 2019-$2.58M–
Q3 FY2019Sep 30, 2019-$2.83M–
Q2 FY2019Jun 30, 2019-$2.71M–
Q1 FY2019Mar 31, 2019-$2.68M–
Q4 FY2018Dec 31, 2018-$2.74M–
Q3 FY2018Sep 30, 2018-$2.71M–
Q2 FY2018Jun 30, 2018-$2.68M–
Q1 FY2018Mar 31, 2018-$2.40M–
Q4 FY2017Dec 31, 2017-$1.82M–
Q3 FY2017Sep 30, 2017-$1.43M–
Q2 FY2017Jun 30, 2017-$1.93M–
Q1 FY2017Mar 31, 2017-$1.36M–
Q4 FY2016Dec 31, 2016-$1.10M–
Q3 FY2016Sep 30, 2016-$933.83K–

More Myomo figures

See a number that looks wrong?